SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Share Buy-Back Programme

27 Jun 2024 18:01

RNS Number : 2414U
Rotork PLC
27 June 2024
 

 

Rotork plc

Share buy-back programme - Tranche 3

27 June 2024

 

As announced at the preliminary results on 5 March 2024, Rotork plc ('Rotork' or the 'Company') commenced a share buyback programme (the 'Programme') to repurchase ordinary shares of 0.5 pence each in the capital of the Company ('Ordinary Shares') of up to £50 million (excluding stamp duty and expenses). Our financial flexibility enables us to pursue strategic investments and we remain active in looking for suitable opportunities, consistent with our Growth+ strategy.

 

The third tranche will be carried out through an irrevocable non-discretionary agreement with Morgan Stanley & Co. International Plc ('MS'), pursuant to which MS shall purchase Ordinary Shares as riskless principal (and not as agent of Rotork) for the subsequent sale on to, and purchase by, Rotork. The third tranche of the Programme will commence on the later of 8 July 2024 and the day following the completion of the second tranche and end no later than 6 September 2024. The aggregate purchase price of all Ordinary Shares acquired under the third tranche of the Programme will be no greater than £10 million (excluding stamp duty and expenses). Any purchases under the Programme will take place in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at the Company's 2024 Annual General Meeting (the '2024 Authority'). The maximum number of Ordinary Shares that the Company is authorised to purchase under the 2024 Authority is 86,125,908 Ordinary Shares. MS will make its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company. Any Ordinary Shares purchased by the Company will be cancelled.

 

Any purchase of Ordinary Shares in relation to the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with (and subject to limits prescribed by) the Company's 2024 Authority, Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). Rotork will announce any market repurchases of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

Enquiries to:

 

Nick Hasell/Susanne Yule, FTI Consulting

Tel: +44 (0)20 3727 1340

Andrew Carter, Investor Relations Director, Rotork Plc

Tel: +44 (0) 1225 733 200

 

Legal Entity Identifier: 213800AH5RZIHGWRJ718

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFERRTIDFIS
Date   Source Headline
19th Jan 20184:47 pmRNSDirector/PDMR Shareholding
19th Jan 20184:46 pmRNSDirector/PDMR Shareholding
4th Jan 20187:00 amRNSChief Executive Appointment
2nd Jan 20184:34 pmRNSTotal Voting Rights
2nd Jan 20184:33 pmRNSBlock listing Interim Review
27th Dec 20177:00 amRNSDirector Declaration
21st Dec 20172:49 pmRNSDirector/PDMR Shareholding
21st Dec 20172:43 pmRNSDirector/PDMR Shareholding
21st Dec 20172:42 pmRNSDirector/PDMR Shareholding
12th Dec 20174:12 pmRNSDirector/PDMR Shareholding
4th Dec 20174:44 pmRNSTotal Voting Rights
23rd Nov 20177:00 amRNSTrading Update
22nd Nov 20179:47 amRNSDirector/PDMR Shareholding
22nd Nov 20179:46 amRNSDirector/PDMR Shareholding
22nd Nov 20179:46 amRNSDirector/PDMR Shareholding
8th Nov 20175:53 pmRNSDirector Declaration
2nd Nov 201710:05 amRNSTotal Voting Rights
23rd Oct 201710:20 amRNSHolding(s) in Company
23rd Oct 201710:14 amRNSDirector/PDMR Shareholding
23rd Oct 201710:13 amRNSDirector/PDMR Shareholding
23rd Oct 201710:13 amRNSDirector/PDMR Shareholding
26th Sep 201711:43 amRNSDirector/PDMR Shareholding
26th Sep 201711:42 amRNSDirector/PDMR Shareholding
26th Sep 201711:40 amRNSDirector/PDMR Shareholding
4th Sep 201710:40 amRNSDirector/PDMR Shareholding
22nd Aug 201710:46 amRNSDirector/PDMR Shareholding
8th Aug 20177:01 amRNSDirectorate Change
8th Aug 20177:00 amRNSRotork plc 2017 Half Year Results
1st Aug 20172:28 pmRNSTotal Voting Rights
28th Jul 20177:00 amRNSDirectorate Change
21st Jul 20173:16 pmRNSDirector/PDMR Shareholding
4th Jul 20175:02 pmRNSBlock listing Interim Review
4th Jul 20174:52 pmRNSTotal Voting Rights
21st Jun 201712:31 pmRNSDirector/PDMR Shareholding
6th Jun 201712:40 pmRNSDirector/PDMR Shareholding
1st Jun 20171:50 pmRNSTotal Voting Rights
31st May 20174:20 pmRNSHolding(s) in Company
23rd May 20172:20 pmRNSDirector/PDMR Shareholding
11th May 20172:19 pmRNSDirector/PDMR Shareholding
8th May 20173:18 pmRNSDirector/PDMR Shareholding
8th May 20173:17 pmRNSDirector/PDMR Shareholding
8th May 20173:15 pmRNSDirector/PDMR Shareholding
2nd May 201711:24 amRNSTotal Voting Rights
28th Apr 20173:36 pmRNSAGM 2017 Result & Statement
28th Apr 20177:00 amRNSTrading update
10th Apr 201711:58 amRNSHolding(s) in Company
5th Apr 20173:21 pmRNSDirector/PDMR Shareholding
3rd Apr 20174:32 pmRNSTotal Voting Rights
29th Mar 201711:46 amRNSDirector/PDMR Shareholding
29th Mar 201711:45 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.